Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Methacholine for Inhalation in Asthma
NCT06725641Phase 4Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Feb 2024
- Primary completion
- Oct 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methacholine in asthma, sponsored by China-Japan Friendship Hospital. Started Feb 2024; status: completed.
02
Drugs
methacholine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06725641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06725641.